Internal Medicine · Brick, NJ
NPI
1336309673
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
525 Jack Martin Blvd, 300
Brick, NJ, 08724
Phone (732) 840-0067
Groups this clinician bills Medicare through
Medicare paid, 2024
$178K
1,837 services
Medicare patients, 2024
948
Average age 75
Drug cost, 2024
$2.6M
2,207 prescriptions
Company payments, 2025
$2,759
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian Wolfman was code 99232 (hospital e&m - subsequent), 454 times for 301 patients. In total Brian Wolfman billed 1,837 services in 50 codes, and Medicare paid $178K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 454 | 301 | $64.44 | $29K |
| 99214 Office E&M - Established | Office | 309 | 246 | $96.39 | $30K |
| 99222 Hospital E&M - Initial | Facility | 161 | 159 | $100.03 | $16K |
| 43239 Upper GI Endoscopy | Facility | 137 | 136 | $91.72 | $13K |
| 99204 Office E&M - New | Office | 128 | 128 | $120.02 | $15K |
| 99213 Office E&M - Established | Office | 110 | 101 | $72.53 | $7,979 |
| 45380 Lower GI Endoscopy - Other | Facility | 110 | 108 | $98.16 | $11K |
| 45385 Colonoscopy - Lesion Removal | Facility | 90 | 89 | $194.77 | $18K |
| 99203 Office E&M - New | Office | 44 | 44 | $88.18 | $3,880 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 25 | 25 | $179.70 | $4,493 |
| 99233 Hospital E&M - Subsequent | Facility | 23 | 17 | $90.05 | $2,071 |
| 45390 Lower GI Endoscopy - Other | Facility | 22 | 22 | $287.54 | $6,326 |
| 99231 Hospital E&M - Subsequent | Facility | 19 | 14 | $36.68 | $697 |
| 45378 Lower GI Endoscopy - Other | Facility | 13 | 13 | $151.66 | $1,972 |
| 43450 Digestive/Gastrointestinal | Facility | 13 | 13 | $33.91 | $441 |
By year: 2022 $156K for 1,541 services; 2023 $178K for 1,806 services; 2024 $178K for 1,837 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brian Wolfman prescribed most often to Medicare patients was Omeprazole, with 407 prescriptions and refills. In total Brian Wolfman wrote 2,207 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 407 | 1,013 | 143 | $5,946 |
| Pantoprazole Sodium Generic | 302 | 811 | 93 | $5,863 |
| Linzess Linaclotide | 125 | 182 | 28 | $98K |
| Dexlansoprazole Dr Dexlansoprazole | 121 | 269 | 36 | $40K |
| Nortriptyline Hcl Generic | 107 | 249 | 40 | $1,324 |
| Famotidine Generic | 92 | 221 | 25 | $1,414 |
| Dicyclomine Hcl Generic | 82 | 131 | 44 | $2,081 |
| Esomeprazole Magnesium Generic | 61 | 149 | 15 | $1,688 |
| Alosetron Hcl Generic | 58 | 64 | Under 11 | $39K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 43 | 50 | 14 | $874 |
| Ondansetron Odt Ondansetron | 42 | 44 | 19 | $1,188 |
| Viberzi Eluxadoline | 40 | 52 | Under 11 | $77K |
| Erythromycin Ethylsuccinate Generic | 35 | 35 | Under 11 | $21K |
| Sucralfate Generic | 33 | 54 | 14 | $3,251 |
| Stelara Ustekinumab | 33 | 46 | Under 11 | $916K |
Brand drugs: 520 claims; generic drugs: 1,687 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian Wolfman $2,759 ($2,759 in general payments such as food, travel and fees) from 18 companies. The largest payer was Janssen Biotech, Inc. with $642.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 17 | $642 |
| Abbvie Inc. ABBV | 32 | $460 |
| Pfizer Inc. PFE | 18 | $296 |
| Mallinckrodt Hospital Products Inc. | 2 | $268 |
| Lilly USA, LLC LLY | 18 | $216 |
| Gilead Sciences, Inc. GILD | 11 | $180 |
| Genzyme Corporation SNY | 9 | $167 |
| Madrigal Pharmaceuticals MDGL | 7 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $85.99 |
| Ardelyx, Inc. ARDX | 5 | $74.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.